ArticleFuture science OA2025
Prevalence of pain and literacy in patients with diabetic peripheral neuropathy in Portugal: the REGENERAR registry study.
Article in Future science OA, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Why are we still missing the pain? Rethinking diabetic neuropathy in primary care - lessons from the REGENERAR study.Future science OA · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimThe REGENERAR registry study aimed to assess the prevalence of pain among Diabetic Peripheral Neuropathy (DPN) patients and to evaluate their health literacy and quality of life.
methodsREGENERAR was a prospective, multicentric registry study conducted in primary healthcare units across Portugal. Adults with DPN were enrolled between April and September 2023. Sociodemographic and clinical information, including pain, neuropathic pain, literacy and quality of life were collected at inclusion visit (V1) and end-of-study visit (V2).
resultsThe study enrolled 127 patients, 120 of whom completed V2. At V1, 77.5% of participants reported pain (61.7% at V2, p < 0.001), with neuropathic pain prevalence, assessed by clinical findings and result of DN4 questionnaire, being 48.3% at V1 and 46.7% at V2. Patient literacy on pain as a diabetes
conclusionThe REGENERAR registry highlights a high prevalence of pain among DPN patients in Portugal, exceeding international figures, but consistent with literature concerning neuropathic pain. It also identifies critical gaps in both patient and healthcare provider literacy. Addressing these gaps could improve disease management and quality of life.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.